SC, S., K, G., K, W., C, M., I, T., P, T., & S, T. (2021). Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study. Dove Medical Press.
Cita Chicago Style (17a ed.)SC, Shrestha, Ghebremeskel K, White K, Minelli C, Tewfik I, Thapa P, y Tewfik S. Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An Ex Vivo Study. Dove Medical Press, 2021.
Cita MLA (8a ed.)SC, Shrestha, et al. Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An Ex Vivo Study. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.